Atypical Hemolytic Uremic Syndrome Drug Market: Trends, Forecast, and Competitive Analysis to 2031

Market Overview and Report Coverage Atypical Hemolytic Uremic Syndrome (aHUS) is a rare disease that affects the kidneys and other organs, leading to potentially life-threatening complications. The current drug used for aHUS is eculizumab, which is a...